
Goldenrod Therapeutics, .
Developing novel therapeutics for rare and underserved diseases.
About
Goldenrod Therapeutics is developing next-generation, brain-penetrant phosphodiesterase 4 (PDE4) inhibitors for multiple neurological indications, including Friedreich’s ataxia, other neurodegenerative diseases, substance use disorders, and pain. Their oral, small molecule drugs are designed for high central nervous system exposure and improved tolerability, aiming to address significant unmet medical needs.
Similar companies
Developing novel therapeutics for rare genetic diseases with a focus on protein degradation.
Shares Biotech, Drug Discovery
Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.
Shares Biotech, Drug Discovery
Biopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier.
Shares Biotech, HealthTech
AI-guided drug discovery platform for tissue-targeted medicines.
Shares Biotech, Drug Discovery
Developing engineered biologics to harness the immune system for disease treatment.
Shares Biotech, Drug Discovery
Developing novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer.
Shares Biotech, Drug Discovery
Key facts
- Website
- goldenrodtx.com
- Headquarters
- San Diego, United States
- Founded
- 2017
- Total funding
- $1M (Seed)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 1 Jan 2017 | Seed | $1M |
Tech stack
Detected on goldenrodtx.com, last scanned 18 Oct 2026. Run your own scan
- CMS / Builders
- Squarespace
- Email provider
- Google Workspace
Goldenrod Therapeutics, . scores 9. Does yours?
That is its Ahrefs DR: the backlink strength of a domain, on the Ahrefs 0 to 100 scale. Paste your website and you get yours in about a minute.
Frequently asked
Is Goldenrod Therapeutics, . trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Goldenrod Therapeutics, . is 76 out of 100, a generally safe rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has Goldenrod Therapeutics, . raised?
Goldenrod Therapeutics, . has raised a total of $1M in funding. The most recent round on record is Seed.
Public record
SEC filings, insider activity, nonprofit links and pay benchmarks for Goldenrod Therapeutics, .


